8-K: cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock

cbdMD, Inc. announces shareholder approval for the automatic conversion of Series A Preferred Stock into common stock, expected to eliminate $6.7 million in accrued dividend payments and $4 million in annual dividend obligations.

Summary

• cbdMD, Inc. held its 2025 annual meeting of shareholders on April 10, 2025.
• Shareholders approved the automatic conversion of Series A Preferred Stock into common stock.
• Each share of Preferred Stock will be converted into thirteen shares of Common Stock, inclusive of all accumulated and unpaid dividends.
• The company intends to set a mandatory exchange date for the Preferred Stock in the near future.
• The conversion is expected to eliminate approximately $6.7 million in accrued dividend payments as of March 31, 2025, and $4 million in annual dividend obligations.
• Shareholders also elected seven directors, ratified the appointment of Cherry Bekaert LLP as the independent auditor, and approved an amendment to allow a reverse stock split ranging from 1:3 to 1:10.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the expected improvement in the company's financial structure and flexibility, although risks related to market conditions and continued listing remain.

Positives

• The automatic conversion of Series A Preferred Stock is expected to eliminate $6.7 million in accrued dividend payments and $4 million in annual dividend obligations.
• The conversion will enhance the company's capital structure and provide flexibility for growth initiatives.
• The company believes the conversion removes a large impediment to more strategic activity along with M&A.
• The conversion will strengthen the balance sheet, meeting shareholders equity requirements for the continued listing of the Common Stock on the NYSE American.

Risks

• The company's future performance is subject to risks and uncertainties, including those related to continued listing on the NYSE American.
• Failure to develop and sell new products could negatively impact the company.
• Market impact and dilutive effects on the stock price are potential risks.

Future Outlook

The company anticipates that the conversion will enhance its capital structure, provide flexibility for growth initiatives, and strengthen its balance sheet, meeting shareholders equity requirements for continued listing on the NYSE American.

Management Comments

• 'We are excited to announce this conversion, which is expected to eliminate approximately $6.7 million in accrued dividend payments as of March 31, 2025 and $4 million in annual dividend obligations,' said Ronan Kennedy, Chief Executive Officer and Chief Financial Officer of cbdMD.
• 'This will allow us to reinvest this capital into our growth initiatives.'
• 'This conversion will enhance our capital structure and provide us with the flexibility needed to continue delivering value to our shareholders.'
• 'We believe that this conversion removes a large impediment to more strategic activity along with M&A and will strengthen our balance sheet, meeting our shareholders equity requirements for the continued listing of our Common Stock on the NYSE American.'

Industry Context

This announcement reflects a strategic move by cbdMD to improve its financial position and potentially pursue M&A opportunities in the competitive CBD and cannabis-infused beverage market.

Comparison to Industry Standards

• Many companies in the cannabis industry are restructuring their capital to improve balance sheets and attract investment.
• The reverse stock split is a common tactic used by companies to maintain listing requirements on exchanges like NYSE American.
• Eliminating preferred stock dividends is a typical step to free up cash flow for growth initiatives, similar to actions taken by other companies in the sector facing financial constraints.

Stakeholder Impact

• Shareholders will see a change in the capital structure with the conversion of preferred stock to common stock.
• The company expects to deliver value to shareholders through enhanced capital structure and growth initiatives.
• The company's ability to maintain its listing on the NYSE American is important for shareholder confidence.

Next Steps

• The company intends to set a mandatory exchange date for the Preferred Stock in the near future.
• The board of directors may implement a reverse stock split at a ratio between 1:3 and 1:10 before the one-year anniversary of the annual meeting.

Key Dates

Keywords

cbdMD, Series A Preferred Stock, Automatic Conversion, Shareholder Meeting, Reverse Stock Split, Dividends, Capital Structure, NYSE American, CBD, Cannabis